Royal Bank of Canada Reiterates “€300.00” Price Target for adidas (FRA:ADS)

Share on StockTwits

Royal Bank of Canada set a €300.00 ($348.84) price objective on adidas (FRA:ADS) in a research report report published on Wednesday, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.

Several other research analysts have also issued reports on the company. Macquarie set a €330.00 ($383.72) target price on adidas and gave the stock a buy rating in a research report on Wednesday, October 9th. UBS Group set a €268.00 ($311.63) target price on adidas and gave the stock a neutral rating in a research report on Thursday, August 8th. HSBC set a €300.00 ($348.84) target price on adidas and gave the stock a neutral rating in a research report on Friday, October 18th. Baader Bank set a €290.00 ($337.21) target price on adidas and gave the stock a neutral rating in a research report on Wednesday. Finally, Pareto Securities set a €225.00 ($261.63) target price on adidas and gave the stock a neutral rating in a research report on Thursday, August 8th. One investment analyst has rated the stock with a sell rating, thirteen have issued a hold rating and six have issued a buy rating to the company. adidas currently has an average rating of Hold and a consensus target price of €274.42 ($319.09).

Shares of FRA:ADS opened at €272.00 ($316.28) on Wednesday. adidas has a 12-month low of €163.65 ($190.29) and a 12-month high of €201.01 ($233.73). The business has a fifty day simple moving average of €277.47 and a 200 day simple moving average of €267.72.

About adidas

adidas AG, together with its subsidiaries, designs, develops, produces, and markets athletic and sports lifestyle products worldwide. The company operates in 10 segments: Europe, North America Adidas, North America Reebok, Asia-Pacific, Latin America, Emerging Markets, Russia/CIS, Adidas Golf, Runtastic, and Other Centrally Managed Businesses.

Featured Story: 52-Week High/Low

Analyst Recommendations for adidas (FRA:ADS)

Receive News & Ratings for adidas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for adidas and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.